1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer

Technology appraisal guidance [TA781] Published: 30 March 2022

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 156 KB 30 March 2022  

Final draft guidance

  • Final draft guidance  
  • Public committee slides PDF 1.19 MB 03 March 2022  
  • Final appraisal document Managed access agreement PDF 438 KB 03 March 2022  
  • Final appraisal document PDF 271 KB 03 March 2022  
  • Committee papers PDF 10.13 MB 25 April 2022  

Invitation to participate

  • Equality impact assessment (Scoping) PDF 123 KB 26 April 2021  
  • Final scope PDF 260 KB 26 April 2021  
  • Final stakeholder list PDF 210 KB 26 April 2021  
  • NICE's response to comments on the draft scope and provisional stakeholder list PDF 229 KB 26 April 2021  

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

  • Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators  
  • Draft scope post referral PDF 232 KB 08 December 2020  
  • Draft matrix post referral PDF 209 KB 08 December 2020